GlaxoSmithKline Pharmaceuticals board to consider financial results

18 Oct 2012 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on November 09, 2012, to consider, approval of unaudited financial results for the quarter ended September 30, 2012 (Q3).

The above information is a part of company's filings submitted to BSE.

Glaxosmithkline Phar Share Price

2643.60 24.20 (0.92%)
25-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.45
Dr. Reddys Lab 1305.50
Cipla 1348.55
Zydus Lifesciences 919.40
Lupin 2292.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×